Skip to main content

Table 4 Publication bias

From: Effect of neoadjuvant chemotherapy in patients with gastric cancer: a PRISMA-compliant systematic review and meta-analysis

Outcomes P value for Egger P value for Begg
Resectability 0.363 0.711
OS 0.763 1.000
PFS 0.444 1.000
1-year survival rate 0.376 0.764
2-year survival rate 0.266 1.000
3-year survival rate 0.991 0.806
4-year survival rate 0.065 0.221
5-year survival rate 0.009 0.452
1-year recurrence 0.069 1.000
2-year recurrence 0.242 0.296
3-year recurrence 0.243 0.296
4-year recurrence 0.723 1.000
5-year recurrence 0.887 1.000